Anvisa suspends Janssen batch over possible glass contamination in Imaavy

Brazil's health regulator Anvisa suspended a batch of Janssen's Imaavy 300 mg, used for autoimmune hemolytic anemia, due to possible glass contamination, prompting a recall. The scope of affected patients and any health impacts remain unclear. This is a product-safety action with limited market impact beyond the specific batch.